Source delivered another year of record revenues and profits, exiting the year with good momentum and looking well positioned for a period of sustained underlying growth. Trading is reported to be encouraging and the outlook for 2016 looks positive. The acquisition of Select Pharma Labs in the year was strategically important and analytical testing services are now being rolled out across the wider group. We have updated our forecasts to reflect the new reporting structure and the FY15 outturn. ....